Additional file 3: of Gefitinib provides similar effectiveness and improved safety than erlotinib for east Asian populations with advanced non–small cell lung cancer: a meta-analysis

Figure S3. Cumulative meta-analysis related to ORR associated with gefitinib versus erlotinib. (TIFF 1498 kb)